You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Drug Price Trends for ALBUTEROL SULFATE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ALBUTEROL SULFATE

Average Pharmacy Cost for ALBUTEROL SULFATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALBUTEROL SULFATE 2 MG TAB 69238-1344-01 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 70710-1061-01 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 53489-0176-01 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 68084-0949-95 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 64980-0442-01 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 62135-0671-90 0.33128 EACH 2025-03-19
ALBUTEROL SULFATE 2 MG TAB 68084-0949-25 0.33128 EACH 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Albuterol Sulfate Market Analysis and Price Projections

Introduction to Albuterol Sulfate

Albuterol sulfate is a widely used medication for treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is available in various forms, including inhalers, inhalation solutions, and oral tablets. Here, we will delve into the market analysis and price projections for albuterol sulfate.

Market Size and Growth

The global albuterol sulfate market is experiencing significant growth driven by several key factors. As of 2023, the albuterol sulfate inhalation aerosol market was valued at USD 2.38 billion and is projected to reach USD 4.07 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 7.1% from 2024 to 2031[3].

Drivers of Market Growth

Several factors are driving the expansion of the albuterol sulfate market:

  • Rising Incidences of Respiratory Disorders: The increasing prevalence of asthma and COPD, particularly in urban areas due to air pollution, is a major driver[3].
  • Advancements in Inhalation Therapy: Innovations in inhaler technology, such as metered-dose and dry powder inhalers, are expanding treatment options and improving patient compliance[3].
  • Regulatory Approvals: The approval of generic formulations has made albuterol sulfate more accessible and affordable for a wider population[3].
  • Patient Education and Healthcare Reforms: Initiatives promoting respiratory health awareness and reforms in healthcare policies are also contributing to market growth[3].

Market Segmentation

The albuterol sulfate market is segmented based on product types, applications, and geographical regions.

Product Types

  • Metered Dose Inhalers (MDIs): These are the most common form of albuterol sulfate inhalers and are expected to continue dominating the market due to their ease of use and effectiveness[4].
  • Dry Powder Inhalers (DPIs): DPIs are gaining popularity due to their convenience and the absence of chlorofluorocarbons (CFCs), which are harmful to the environment[4].
  • Inhalation Solutions: These are used for nebulization and are particularly useful for patients who have difficulty using inhalers[5].

Applications

  • Asthma: Albuterol sulfate is widely used for managing acute and chronic symptoms of asthma.
  • COPD: It is also crucial in the management of COPD, helping to alleviate symptoms such as wheezing and shortness of breath[2].

Geographical Regions

The market is analyzed across various regions including North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The Asia-Pacific region is expected to show significant growth due to the large population and increasing incidence of respiratory disorders[1].

Price Projections and Affordability

Retail Prices

The retail prices of albuterol sulfate vary depending on the form and dosage. Here are some average retail prices:

  • Inhalers: The average retail price for 25 units of albuterol sulfate inhalers (2.5 mg/3 mL) is around $54.42. However, prices can be significantly lower with coupons or patient assistance programs, such as SingleCare, which can reduce the cost to around $8.11[2].
  • Inhalation Solutions: Prices range from $18.17 for 75 milliliters (2.5 mg/3 mL) to $32.45 for 30 solutions (2.5 mg/0.5 mL)[5].

Cost Savings

Several programs and coupons are available to help reduce the cost of albuterol sulfate:

  • SingleCare Coupons: These can lower the cost of albuterol sulfate inhalers to as low as $8.11 at participating pharmacies[2].
  • Patient Assistance Programs: Many pharmaceutical companies and non-profit organizations offer assistance programs to make albuterol sulfate more affordable for patients without adequate insurance coverage[5].

Competitive Landscape

The albuterol sulfate market is competitive, with several major players including GSK, Merck, and Teva. These companies are engaged in various strategies such as mergers and acquisitions, expansion activities, and research and development to maintain their market share[1][4].

Key Players

  • GSK: Known for its extensive portfolio of respiratory medications, GSK is a significant player in the albuterol sulfate market.
  • Merck: Merck also has a strong presence with its range of albuterol sulfate products.
  • Teva: Teva, a leading generic pharmaceutical company, offers affordable albuterol sulfate options, contributing to the market's growth[1].

Regulatory and Technological Trends

Regulatory Approvals

The approval of generic formulations has been a significant factor in the market's growth. Regulatory bodies continue to support the development and approval of new formulations and delivery systems, which is expected to further expand the market[3].

Technological Advancements

Advances in inhaler technology, such as the development of breath-activated inhalers and smart inhalers, are improving patient compliance and treatment outcomes. These innovations are expected to drive the market forward in the coming years[3].

Challenges and Opportunities

Challenges

  • Air Pollution and Urbanization: While these factors drive the demand for albuterol sulfate, they also pose significant health challenges that need to be addressed through broader public health initiatives.
  • Competition from Alternative Treatments: The emergence of new treatments for respiratory disorders could pose a challenge to the dominance of albuterol sulfate in the market[3].

Opportunities

  • Emerging Markets: Countries with growing populations and increasing healthcare spending offer significant opportunities for market expansion.
  • Research and Development: Ongoing research into new formulations and delivery systems presents opportunities for innovation and growth[1].

Key Takeaways

  • The global albuterol sulfate market is projected to grow significantly, driven by rising incidences of respiratory disorders and advancements in inhalation therapy.
  • The market is segmented by product types, applications, and geographical regions, with metered dose inhalers being the dominant form.
  • Various programs and coupons are available to make albuterol sulfate more affordable for patients.
  • Major players like GSK, Merck, and Teva are key competitors in the market.
  • Regulatory approvals and technological advancements are expected to continue driving market growth.

FAQs

Q: What is the projected growth rate of the albuterol sulfate market?

A: The albuterol sulfate inhalation aerosol market is expected to grow at a CAGR of 7.1% from 2024 to 2031[3].

Q: What are the main drivers of the albuterol sulfate market?

A: The main drivers include rising incidences of respiratory disorders, advancements in inhalation therapy, regulatory approvals for generic formulations, and increasing air pollution levels[3].

Q: How can patients reduce the cost of albuterol sulfate?

A: Patients can use coupons, patient assistance programs, and shop at pharmacies that offer lower prices to reduce the cost of albuterol sulfate[2][5].

Q: Which companies are major players in the albuterol sulfate market?

A: Major players include GSK, Merck, and Teva[1][4].

Q: What are the potential challenges facing the albuterol sulfate market?

A: Challenges include competition from alternative treatments and the impact of air pollution and urbanization on public health[3].

Sources

  1. Albuterol Sulfate Inhalers Market Comprehensive Report 2024 - OpenPR
  2. Albuterol Sulfate Coupons & Prices - SingleCare
  3. Albuterol Sulfate Inhalation Aerosol Market Size and Projections - Market Research Intellect
  4. Global Albuterol Sulfate Metered Dose Inhalers Market Report 2024 - Cognitive Market Research
  5. Albuterol Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.